News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
46 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21901)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (190)
2 (123)
5 (141)
6 (141)
7 (169)
8 (187)
9 (100)
12 (133)
13 (138)
14 (122)
15 (129)
16 (48)
19 (83)
20 (66)
21 (95)
22 (49)
23 (90)
24 (1)
26 (99)
27 (109)
28 (135)
29 (105)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
24
26
27
28
29
30
Regulatory
J&J Poised to Challenge Argenx With Myasthenia Gravis Filing for Nipocalimab
J&J gained rights to the FcRn blocker nipocalimab when it acquired Momenta Pharmaceuticals in August 2020 for $6.5 billion.
August 30, 2024
·
2 min read
·
Tristan Manalac
Business
Scilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024
August 30, 2024
·
7 min read
Rare diseases
Alnylam Builds ATTR-CM Case for Vutrisiran With Strong Phase III Survival Data
Despite the added survival benefit for its drug, Alnylam still faces steep competition from Pfizer, whose ATTR-CM therapies have become established treatment options.
August 30, 2024
·
2 min read
·
Tristan Manalac
Clinical research
NuCana Shares Plummet as Another Chemotherapy Replacement Fails Phase II
NuCana’s chemotherapy replacement has failed to improve progression-free survival in a Phase II test, sending the biotech’s shares down by 50%.
August 30, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
Amerigo Scientific Releases Customized Bioreactors Optimal for Pilot and Production Scale
August 30, 2024
·
2 min read
Press Releases
Oncology Companion Diagnostic Market Size to Reach USD 12.15 Billion By 2033
August 30, 2024
·
15 min read
Previous
5 of 5
